Déjà vu – memory T cells have seen SARS-CoV-2 before.

Newly-Discovered Is Not New. In early September we first highlighted the incorrect designation of SARS-CoV-2 as a ‘novel’ or ‘new’ coronavirus when it should have been designated ‘newly-discovered’. There is a subtle but fundamental difference: something that is new did not previously exist whereas something that is newly-discovered already existed but not been discovered yet. […]

Read More…


These Are Not The Drugs You Are Looking For.

Don’t Use Remdesivir. Just one month after the US Food and Drug Administration approved remdesivir as an antiviral for the treatment of patients with COVID-19, the WHO yesterday recommended that it not be used, on the basis that it is ineffective and there is “no evidence” it reduces mortality. Last month, we analysed remdesivir’s use […]

Read More…


Monetising A Vaccine Shows What It’s Really All About.

LOADSAMONEY! According to the sales pitch on Thursday from investment banks Credit Suisse and Morgan Stanley, a COVID-19 vaccine could be a “bumper revenue opportunity“, projected to earn at least $10 billion a year. Morgan Stanley’s projection is at least $10 billion a year across developed countries but Credit Suisse is bigging it up further […]

Read More…


An antiviral maybe but a vaccine isn’t needed and wouldn’t be effective.

Apparently everything now hangs on a vaccine: stockmarkets rise and fall on the mere rumour of how the rumoured development of a particular rumoured COVID-19 vaccine is going; politicians say that normality can’t be resumed until a vaccine is available; people are fed the line that a virus must have a vaccine and that without […]

Read More…


Does Ibuprofen make SARS-CoV-2 better or worse? Here are two strong reasons not to take it.

Background Back in April we first wrote about a possible connection between the increasingly above-average mortality rates in European countries and their widespread use of non-steroidal anti-inflammatory drugs (NSAIDs) such as Ibuprofen. We raised the question as to whether the cyclooxygenase (COX) enzyme inhibitor function of NSAIDs either intefered with or amplified the angiotensin-converting enzyme […]

Read More…


Vitamin D, eNOS and NO – your partners in fighting SARS-CoV-2

An Achilles heel Following on from our first article last month on key reasons why the UK government strategy & response have been so wrong and caused the deaths of tens of thousands of people, this article outlines the key roles of vitamin D, endothelial nitric oxide synthase (eNOS or NOS3) and nitric oxide in […]

Read More…


Lockdown kills. Here’s why…

UK vs Average Worldwide Mortality Rate As a baseline, the average worldwide mortality rate for SARS-CoV-2 is currently 0.012% (source: Johns Hopkins Coronavirus Resource Center and Worldmeters @ 0500 20/09/20).  The UK mortality rate is 0.061% – that’s 5x higher than the worldwide average.  From the onset of the Great Insanity, the UK mortality rate […]

Read More…


Recombination and re-recombination: how SARS-CoV-2 mixes it up.

Lots of coverage is given to talking about how ‘the coronavirus’ could mutate and spawn new and ever more deadly strains – this despite it apparently already being the most deadly virus in the history of the world ever, which you would think doesn’t really leave it any scope to get worse – as part […]

Read More…